Effect of CYP2C19 polymorphism on response to bortezomib-based therapy in multiple myeloma patients
Article in The American Journal of the Medical Sciences (March 2024)
The most recent citing publications are shown below. View all 22 publications that cite this research output on Dimensions.
A genetic variant study of bortezomib-induced peripheral neuropathy in Chinese multiple myeloma patients
Article in Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (January 2024)
CYP2C19 polymorphism has no correlation with the efficacy and safety of thalidomide in the treatment of immune‐related bowel disease
Article in Journal of Digestive Diseases (February 2020)